©2015 MFMER | slide-1 Stress Testing in Women Todd D. Miller, M.D. Mayo Clinic Rochester, MN Disclosures:

Slides:



Advertisements
Similar presentations
Myocardial Perfusion SPECT Should NOT Be Routine in Symptomatic Patients with Excellent Exercise Capacity V. Froelicher, MD Professor of Medicine Stanford.
Advertisements

How to Use Heart Rate Changes to Improve Exercise Test Results V. Froelicher, MD Professor of Medicine Stanford University VA Palo Alto HCS.
Better Medical Diagnostic Decisions thru Science V. Froelicher, MD Professor of Medicine Stanford University VA Palo Alto HCS Optimal Clinical Application.
PET AND PET/CT IN ISCHEMIC HEART DISEASE
Karam Paul MS, MD, MBA, FACC Community Heart and Vascular.
Controversies in Myocardial Perfusion Imaging Thomas H. Hauser, MD, MMSc, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center Instructor.
B. C. Kansupada, MD, HeartCare Assoc. ACC chapter talk 4/28/06.
ACRIN PA 4005: Multicenter Randomized Controlled Study of a Rapid ‘Rule-out’ Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk.
Stress Testing : Which Test to Choose?
Cardiac Stress Testing. What is a stress test? A progressive graded test that reproduces diagnostic, prognostic, and functional abnormalities in clients.
CP Wennberg et al: The Dartmouth Atlas of Cardiovascular Health Care, 1999 Rates of Imaging Stress Testing # 1000 enrollees # 1000 enrollees.
Prognostic Value of Myocardial Perfusion Imaging over Duke Treadmill Score Ethan Levine, D.O., Regina S. Druz, M.D., FACC Department of Cardiology, State.
Heart Failure with Normal Systolic Function: Better or Worse Prognosis? Maria Rosa Costanzo, M.D., F.A.C.C, F.A.H.A. Medical Director, Midwest Heart Specialists.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
Clinical Trials. Date & location – January-November 1998, stress SPECT patients randomly received tetrofosmin or sestamibi (n~1550) Inclusion criteria.
Overview of Adult Cardiovascular Disease Social Security Administration Compassionate Allowances Outreach Hearing on Cardiovascular Disease and Multiple.
CHAPTER SIX Interpretation of Clinical Test Data Posttest probability of disease is determined by pretest probability and the probability of the test providing.
“Acute Coronary Syndromes: Trials & Tribulations" Will Southern, M.D., M.S. Director of Hospitalist Services Associate Medical Director Weiler Division.
Noninvasive Technologies for Diagnosing Coronary Artery Disease in Women Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Exercise –induced ST Elevation Dr sajeer K T Senior Resident, Dept. of Cardiology Medical College, Calicut.
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 FEDERICA.
Modalities of Cardiac Stress Test
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
How Much Exercise Is Necessary to Prevent CV Disease? Thomas G. Allison, PhD, MPH Mayo Clinic, Rochester, MN, USA.
Screening for CAD: What Test to Order for Which Situation
Exercise Treadmill Testing
Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.

Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Chest pain in Women Deborah B. Diercks, MD, MSc Professor of Emergency Medicine University of California, Davis Medical Center Disclosures: Grant and Research.
Myocardial Ischemia Redefined: Optimal Care in CAD.
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT Saving Our Law Officers From Sudden Death and Heart Attacks.
Stress Testing and You: A Guide for the Interventionalist Matthew Schumaecker, MD Carilion Clinic April 7, 2014.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
CLINICAL EXERCISE TESTING To evaluate person’s ability to tolerate increasing levels of work output parameters measured include but are not limited to.
Silent Ischemia STABLE CAD
Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Likelihood 2005/5/22. Likelihood  probability I am likelihood I am probability.
Sensitivity is True positives 60 Total CAD 100 Sensitivity and Specificity CAD by CAG No CAD by CAG TMT + VE True Positives 60 False Positives 60 TMT –
در مرکز پزشکی هسته ای دکتر دباغ – دکتر صادقی در خدمت شما هستیم مشهد، ملاصدرا 11 ، پلاک 1/4 Tel:+98(51) ; +98(51)
All Rights Reserved, Duke Medicine 2008 Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does It Predict Mortality? Paul L. Hess, MD; Linda.
BASICS OF STRESS TESTING
The Century Health Trial A Comprehensive Integrated Strategy For Managing CAD K. Lance Gould, M.D. Martin Bucksbaum Distinguished University Chair, Professor.
Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.
Insights from the PROMISE Trial Neha J. Pagidipati, MD MPH; Kshipra Hemal; Adrian Coles, PhD; Daniel B. Mark, MD MPH; Rowena J. Dolor, MD MHS; Patricia.
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Dr Cristina Constantin Consultant Cardiologist Princess of Wales Hospital.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.
Prognostic value of MPI S.R.Zakavi,MD.IBNM Nuclear Medicine Research Center, Mashhad University of Medical Sciences Mashhad, Iran
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Acute changes in circulating natriuretic peptide.
Screening for CAD Nuclear Medicine prospective S.R.Zakavi,MD,IBNM Nuclear Medicine Research Center Mashhad University of Medical Sciences.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Women and Cardiovascular Disease
Zoll Firm Lecture Series
Boston University Medical Center Boston , MA
Prognosis of Patients With LV Dysfunction and CAD
Cardiac Indices in Myocardial Perfusion Scan and Their Impact on the Patient's Prognosis
18th Annual Primary Care and Cardiovascular Symposium
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Validation of a Clinical Pathway to Assess Asymptomatic.
CT for Evaluation & Treatment of Cardiovascular Disease
Revascularization in Patients With Left Ventricular Dysfunction:
Clinical need for determination of vulnerable plaques
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Prediction of 14-year cardiovascular outcomes by dobutamine.
The role of treadmill exercise testing in women
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
CHEST PAIN Evaluation and Diagnostic Testing
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT
Presentation transcript:

©2015 MFMER | slide-1 Stress Testing in Women Todd D. Miller, M.D. Mayo Clinic Rochester, MN Disclosures:

©2015 MFMER | slide-2 Purposes of Stress Testing Diagnosis (probability) CAD Prognosis (risk stratification) Other

©2015 MFMER | slide-3 Factors Affecting Diagnostic Accuracy Exercise ECG Prevalence CAD in population (Sp = ) Exercise performance Resting ECG Medications Gender specific Hormone status (digoxin) Abnormal coronary tone Microvascular disease TN TN + FP

MI/CD By Age and Sex ARIC and CHS Mozaffarian D. Circulation 2015;131:e29-e322 New and Recurrent MI or Fatal CHD per 1,000 Age (Years)

Effect Hormone Therapy Exercise ECG Bokhari S. JACC 2002;40:1092 * Percentage

Meta-Analysis Exercise ECG % Gianrossi R. Circ 1989;80:87 Kwok Y. AJC 1999;83:660

Verification Bias Begg CB and Greenes RA: Biometrics 39:207, 1983 Diamond GA: AJC 5:1175, 1986 Se = TP TP + FN Sp = TN TN + FP Cath 125 Cath 125 No cath 735 No cath 735 Cath 15 No cath 125 No cath 125 (–) Test 750 (–) Test 750 (+) Test 250 (+) Test 250 1,000 pt Se = TP + FN FP Sp = TN TN +

Exercise ECG MPI Reference Standard Miller TD. AJC 2001;87:868 %

Impact of Verification Bias – Women Roger VL. Circ 1997;95:405 Miller TD. AJM 2002;112:290 Sensitivity % % Specificity Apparent Adjusted

CAD Prognostic Index Annual mortality (%) Califf RM: JACC 27:964, 1996

Prognostic Value Exercise Capacity St. James WTH Project Exercise Capacity Categories Gulati M. Circulation 2003;108;1554 Hazards Ratio of Death 2.0 ( ) 3.1 ( ) 1.9 ( ) 1.0

Duke Treadmill Score Annual CV mortality (%) Mark DB: NEJM 325:849, 1991 (  5) Score = Duration (min Bruce protocol) – (5x ST-seg deviation)(mm) – (4x angina index)(0, 1, 2) Score = Duration (min Bruce protocol) – (5x ST-seg deviation)(mm) – (4x angina index)(0, 1, 2) (-10 to +4)(<-10) CP

©2015 MFMER | Duke Treadmill Score Alexander K. J Am Coll Cardiol1998;32:1657 WomenMen Years Probability of survival Low Moderate High Low Moderate High

WOMEN Trial n = 824 Costs ETT $338 MPI $643 % MACE Shaw LJ. Circ 2011;124: % 1.2% 5.1% 13.1% Test Results p=0.40 p=0.19 p<0.001 MACE 17 CD 1 MI 3 Hosp 13

©2013 MFMER | Risk Stratification in the Elderly (Age ≥75) Cardiac Survival Duke Score % Years SPECT Years P=0.4519P<0.001 Low Intermediate High Kwok JMF. JACC 2002;39:1475Valeti US. Circ 2005;111: % 85% 69% 95% 93% 60% Duke ScoreSPECT Kwok JMF. JACC 2002;39:1475Valeti US. Circ 2005;111:1771 Low 25% Intermediate 70% Intermediate 16% Low 49% High 35% High 5% Duke scoreSPECT Low Intermediate High Annual cardiac mortality (%)

Survival Free of CD SSS Women At risk (no.) Low Intermediate High Years % Low High Intermediate P= % 92% 69%

Cancer Incidence in Women Gerber TC. JACC Cardiovasc Imaging 2010;3:528

©2015 MFMER | Conclusions Standard ETT and stress imaging modest value diagnosis CAD Most important role of stress testing risk stratification CAD Apply all available information to patient management and not just ischemia Approach standard ETT when appropriate as initial test most cost effective

Recommendations Individual Stress Modalities VariableETTImaging* Pre-test prob CADIntermediateHigh ** Able to exercise *** YesNo Interpretable ECG **** YesNo Prior false (+), indeterminate ETTNoYes * Pre-menopausal  no radiation ** Includes elderly (> age 75 yrs) *** 5 METs **** Paced, LBBB, WPW, ≥ 0.5 mm ST ↓ Mieres JH. Circ 2014;130:350